Middle East Journal of Cancer

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Forms

Journal Metrics

Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk: A Matched Case-Control Study

Document Type : Original Article(s)

Authors

1 Department of Surgery, Zanjan University of Medical Sciences, Zanjan, Iran

2 Department of Hematology-Oncology, School of Medicine, Zanjan, University of Medical Sciences, Zanjan, Iran

3 Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

4 Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran

5 Department of Epidemiology and Statistics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Abstract

Background: The protective role of vitamin D in the occurrence of breast cancer is nowadays a controversial matter. Based on conflicting results of the studies in this field and also considering the prevalence of vitamin D deficiency in Iranian women, this work was conducted to evaluate the association between vitamin D and breast cancer.
Method: This matched case-control study was conducted on 70 newly diagnosed breast cancer patients and 70 controls with the same age, menopause status, and time of blood sampling in Zanjan. Information regarding demographic, reproductive, history of diseases, medication, use of dairy products, and sunlight exposure was collected using a questionnaire. The serum level of vitamin D was measured with ELISA method. The data were analyzed utilizing chi-square test, independent t-test, and odds ratios using conditional logistic regression model.
Results: The mean level of vitamin D was 39.04 and 63.34 ng/ml in the cases and controls, respectively (P=0.046). The proportion of the cases in the highest quartile of vitamin D was significantly smaller than that in the controls compared with the lowest quartile (Ptrend=0.028). Using conditional logistic regression model, an inverse and independent association was observed between vitamin D and breast cancer after controlling main confounders. The risk of breast cancer was independently associated with body mass index and low income.
Conclusion: In this study, an inverse association was confirmed between vitamin D and breast cancer. Prospective intervention studies should be performed to explore its role in the prevention of breast cancer.

Keywords

Full Text

How to cite this article:

Fakour F, Moghimi M, Esmaeilzadeh A, Kalantari F, Eskandari F, Biglari S, et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk: A matched case-control study. Middle East J Cancer. 2022;13(1):81-8. doi: 10.30476/mejc.2021.85406.1279.

References
  1. Anderson LN, Cotterchio M, Vieth R, Knight JA. Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr. 2010; 91(6):1699-707. doi:10.3945/ajcn.2009.28869.
  2. Lee MS, Huang YC, Wahlqvist ML, Wu TY, Chou YC, Wu MH, et al. Vitamin D decreases risk of breast cancer in premenopausal women of normal weight in subtropicaltaiwan. J Epidemiol. 2011; 21(2):87-94. doi:10.2188/jea.je20100088.
  3. Kawase T, Matsuo K, Suzuki T, Hirose K, Hosono S, Watanabe M, et al. Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan. Cancer Sci. 2010; 101(5):1234-40. doi: 10.1111/j.1349-7006.2010.01496.x.
  4. Rossi M, McLaughlin JK, Lagiou P, Bosetti C, Talamini R, Lipworth L, et al. Vitamin D intake and breast cancer risk: a case-control study in Italy. Ann Oncol. 2009; 20(2):374-8. doi:10.1093/annonc/mdn550.
  5. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med. 2007;167(10):1050-9. doi: 10.1001/archinte.167.10. 1050.
  6. Robien K1, Cutler GJ, Lazovich D. Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study. Cancer Causes Control. 2007;18(7):775-82. doi: 10.1007/s10552-007-9020-x.
  7. Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol Biomarkers Prev. 2011; 20(1):187-98. 114000. doi: 10.1158/1055-9965.EPI-10-1039.
  8. Eliassen AH, Spiegelman D, Hollis BW, Horst RL, Willett WC, Hankinson SE. Plasma 25- hydroxyl vitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res. 2011;13(3): R50. doi:10.1186/bcr2880.
  9. Amir E, Cecchini RS, Ganz PA, Costantino JP, Beddows S, Hood N, et al. 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABPP1. Breast Cancer Res Treat. 2012; 133(3):1077-88. doi:10.1007/ s10549-012-2012-x.
  10. Engel P, Fagherazzi G, Boutten A, Dupre T, Mesrine S, Boutron-Ruault MC, et al. Serum 25(OH) vitamin D and risk of breast cancer: anested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev. 2010; 19(9):2341-50. doi: 10.1158/ 1055-9965.EPI-10-0264.
  11. Abbas S, Chang-Claude J, Linseisen J. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer. 2009; 124(1):250-5. doi: 10.1002/ijc.23904.
  12. Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila). 2009;2(6):598-604. doi:10. 1158/1940-6207.CAPR-08-0138.
  13. Kim Y, Franke AA, Shvetsov YB, Wilkens LR, Cooney RV, Lurie G, et al. Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study. BMC Cancer. 2014; 14(29). doi:10.1186/1471-2407-14-29.
  14. Bertone-Jsohnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1991-7. doi:10.1158/1055-9965.EPI-04-0722.
  15. John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 1999;8(5):399-406.
  16. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005; 41(8):1164-9. doi:10.1016/j.ejca.2005.01.017.
  17. Alipour S, Hadji M, Hosseini L, Omranipour R, Saberi A, Seifollahi A, et al. Levels of serum 25-hydroxy-vitamin d in benign and malignant breast masses. Asian Pac J Cancer Prev. 2014;15(1):129-32. doi: 10.7314/APJCP.2014.15.1.129.
  18. Bidgoli SA, Azarshab H. Role of vitamin D deficiency and lack of sun exposure in the incidence of premenopausal breast cancer: a case control study in Sabzevar, Iran. Asian Pac J Cancer Prev. 2014;15(8): 3391-6. doi: 10.7314/APJCP.2014.15.8.3391.
  19. Kemmis CM, Salvador SM, Smith KM, Welsh J. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25- hydroxyvitamin D-3, the major circulating form of vitamin D-3. J Nutr. 2006;136:887–92. doi:10.1093/jn/136.4.887.
  20. Holick MF. Vitamin D: biosynthesis, metabolism, and mode of action. In: DeGroot LJ, Cahill GF Jr, Martini L, Nelson DH, Odell WD, Potts JT Jr, et al., editors. Endocrinology. New York: Grune and Stratton, 1989. p. 902-26.
  21. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13:1502-8.
  22. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer. 2010; 46(12):2196-205. doi:10. 1016/j.ejca.2010.03.037.
  23. Jamshidi Naeeni Y, Davoodi H, Esmaeili S. Effects of vitamin D on risk of breast cancer. [In Persian] Iranian J Nutr Sci Food Technol. 2013;7(4):53-62.
  24. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study. Carcinogenesis. 2008; 29(1):93-9. doi:10.1093/carcin/ bgm240.
  25. Hajian K, Gholizadehpasha A, Bozorgzadeh Sh. Association of obesity and central obesity with breast cancer risk in pre- and postmenopausal women. [In Persian] J Babol Univ Med Sci. 2013;15(3):7-15.
Middle East Journal of Cancer
Volume 13, Issue 1 - Serial Number 49
January 2022
Pages 81-88
Files
Share
How to cite
Statistics